These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nociceptive response to innocuous mechanical stimulation is mediated via myelinated afferents and NK-1 receptor activation in a rat model of neuropathic pain. Pitcher GM; Henry JL Exp Neurol; 2004 Apr; 186(2):173-97. PubMed ID: 15026255 [TBL] [Abstract][Full Text] [Related]
25. Chemokine receptors as specific anti-inflammatory targets in peripheral nerves. Ubogu EE Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):141-53. PubMed ID: 21476965 [TBL] [Abstract][Full Text] [Related]
26. Strategies for chemokine antagonists as therapeutics. Proudfoot AE; Power CA; Rommel C; Wells TN Semin Immunol; 2003 Feb; 15(1):57-65. PubMed ID: 12495641 [TBL] [Abstract][Full Text] [Related]
27. Pathways that elicit long-term changes in gene expression in nociceptive neurons following nerve injury: contributions to neuropathic pain. Sung YJ; Ambron RT Neurol Res; 2004 Mar; 26(2):195-203. PubMed ID: 15072639 [TBL] [Abstract][Full Text] [Related]
28. Development and expression of neuropathic pain in CB1 knockout mice. Castañé A; Célérier E; Martín M; Ledent C; Parmentier M; Maldonado R; Valverde O Neuropharmacology; 2006 Jan; 50(1):111-22. PubMed ID: 16169563 [TBL] [Abstract][Full Text] [Related]
29. Shaping the gradient by nonchemotactic chemokine receptors. Borroni EM; Bonecchi R Cell Adh Migr; 2009; 3(2):146-7. PubMed ID: 19279397 [TBL] [Abstract][Full Text] [Related]
30. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Huang D; Han Y; Rani MR; Glabinski A; Trebst C; Sørensen T; Tani M; Wang J; Chien P; O'Bryan S; Bielecki B; Zhou ZL; Majumder S; Ransohoff RM Immunol Rev; 2000 Oct; 177():52-67. PubMed ID: 11138785 [TBL] [Abstract][Full Text] [Related]
32. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Cartier L; Hartley O; Dubois-Dauphin M; Krause KH Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626 [TBL] [Abstract][Full Text] [Related]
33. Chemokines in vascular pathology (review). Apostolakis S; Papadakis EG; Krambovitis E; Spandidos DA Int J Mol Med; 2006 May; 17(5):691-701. PubMed ID: 16596249 [TBL] [Abstract][Full Text] [Related]
34. Role of chemokines and their receptors in the pathogenesis of multiple sclerosis. Sindern E Front Biosci; 2004 Jan; 9():457-63. PubMed ID: 14766382 [TBL] [Abstract][Full Text] [Related]
35. Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges. Trebst C; Ransohoff RM Arch Neurol; 2001 Dec; 58(12):1975-80. PubMed ID: 11735771 [TBL] [Abstract][Full Text] [Related]
36. Chemokines as effector and target molecules in vascular biology. Sozzani S; Del Prete A; Bonecchi R; Locati M Cardiovasc Res; 2015 Aug; 107(3):364-72. PubMed ID: 25969393 [TBL] [Abstract][Full Text] [Related]